[SGMO] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
05-Aug-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 16.27%
YoY- -18.64%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 26,280 25,800 57,763 21,553 13,076 54,851 21,958 12.71%
PBT -45,677 -40,567 -1,271 -35,965 -42,974 4,501 -27,361 40.68%
Tax 262 108 237 -36 -61 179 -54 -
NP -45,933 -40,604 -1,550 -35,929 -42,913 4,555 -27,307 41.39%
Tax Rate - - - - - -3.98% - -
Total Cost 72,213 66,404 59,313 57,482 55,989 50,296 49,265 29.00%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin -174.78 -157.38 -2.68 -166.70 -328.18 8.30 -124.36 25.44%
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -0.32 -0.29 -0.01 -0.26 -0.37 0.04 -0.24 21.12%
EPS Diluted -0.32 -0.29 -0.01 -0.26 -0.37 0.04 -0.24 21.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.